版本:
中国

BRIEF-Ligand Pharmaceuticals enters into agreements with Interventional Analgesix

May 23 Ligand Pharmaceuticals Inc

* On May 22, 2017, entered into a license agreement and a supply agreement with privately-held interventional analgesix, inc

* Agreement grants IAX exclusive right to use Captisol in development and commercialization of Captisol-enabled version of specified compound

* Will receive an upfront payment, and could also potentially receive milestone payments, plus tiered royalties of 5 pct -10 pct of net sales

* Says could receive commercial revenue from shipment of Captisol to IAX for clinical and commercial activities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐